Research Articles
Mapping the Hepatitis C Revolution: How Science Charted the Path to Elimination
Explore the 35-year scientific journey of hepatitis C research through scientific mapping and bibliometric analysis from 1989 to 2022.
From Daunting Challenge to Curable Disease: The Revolution in Hepatitis C Genotype 3 Treatment
Explore the breakthrough interferon-free therapies that have transformed hepatitis C genotype 3 from a challenging condition to a curable disease.
Tiny Victories: How Eight Weeks of Sofosbuvir/Ledipasvir Cured Hepatitis C in a Preschooler
A breakthrough case study showing how 8 weeks of sofosbuvir/ledipasvir cured hepatitis C in a 4-year-old child, revolutionizing pediatric HCV treatment.
The Pregnancy Puzzle: How a Hepatitis C Drug Is Changing Mother-Baby Health
Breakthrough research on using sofosbuvir/velpatasvir (SOF/VEL) to treat Hepatitis C in pregnant women and prevent mother-to-child transmission.
The Unlikely Duo: How Pegylated Interferon and Ribavirin Revolutionized Hepatitis C Treatment
Explore how pegylated interferon and ribavirin combination therapy transformed Hepatitis C treatment before being replaced by direct-acting antivirals.
The 8-Week Revolution: Short-Duration Antivirals Transform Care for Cancer Patients with Hepatitis C
Breakthrough research shows 8-week DAA therapy achieves 100% cure rates in HCV-infected cancer patients, enabling faster oncology treatment without delays.
The Triple Threat: How Three Drugs Joined Forces to Conquer Hepatitis C
Explore how sofosbuvir, pegylated-interferon and ribavirin combination therapy revolutionized Hepatitis C treatment for genotype 1 infection.
The Silent Threat: How Conquering Hepatitis C Is Changing the Liver Cancer Landscape
Exploring how hepatitis C virus eradication transforms hepatocellular carcinoma risk through antiviral therapies and ongoing challenges in liver cancer prevention.